Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran
Christina L Fanola Department of Cardiovascular and Vascular Medicine, Boston University School of Medicine, Boston, MA, USA Abstract: Venous thromboembolism (VTE) is a disease state that carries significant morbidity and mortality, and is a known cause of preventable death in hospitalized and orth...
Main Author: | Fanola CL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/current-and-emerging-strategies-in-the-management-of-venous-thromboemb-peer-reviewed-article-VHRM |
Similar Items
-
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
by: Leung TS, et al.
Published: (2015-07-01) -
Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
by: V.Y. Bogachev, et al.
Published: (2017-12-01) -
Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism
by: Paik, J.
Published: (2022) -
Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01) -
Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery
by: Orietta Zaniolo
Published: (2009-09-01)